AI Terminal
OPKO Health Inc.
Report Publication Announcement • Jan 3, 2023
6963_rns_2023-01-03_bf4cfede-3071-4e46-8a9a-d5b2b577636f.pdf
Report Publication Announcement
Open in ViewerOpens in native device viewer
OPKO Health to Present at the 41st Annual J.P. Morgan Healthcare Conference
MIAMI (January 3, 2023) – OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the 41st Annual J.P. Morgan Healthcare Conference being held January 9-12, 2023 at the Westin St. Francis in San Francisco. Management will be hosting one-on-one meetings with investors and will be presenting on Wednesday, January 11th at 4:30 p.m. Pacific time.
The presentation will be webcast live and available for replay in the Investors section of OPKO Health's website and accessible by clicking here.
About OPKO Health
OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industryleading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.